ReviewNigerian medical journal : journal of the Nigeria Medical Association
Mpox in a Neonate: A Case Report of a 14-day-old Baby in Nigeria.
Review in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human mpox (HMPX) is a zoonotic infection caused by the Monkeypox Virus (MPXV), with commonly reported routes of transmission being contact with infected wildlife, humans, and fomites. More data is needed to establish the frequency of transmission from asymptomatic carriers and from mother to child.Initially confined to 10 West and Central African countries, mpox assumed a global dimension in 2022. Since its first outbreak in 2017, data from Nigeria have consistently shown that the disease predominantly affects young adults aged 21-40 years, in keeping with long-established epidemiological patterns. However, analysis of the 2024 Nigeria Centre for Disease Control (NCDC) situation reports indicates a notable upsurge in reported cases among children aged 0-10 years, even though young adults remain the most affected age group overall. However, there is a paucity of data which highlights presentation in the neonatal age group, which is a rare occurrence.Mpox commonly presents with fever, rash and lymphadenopathy. These symptoms may mimic other childhood skin infections like chicken pox and impetigo; thus, a high index of suspicion is needed among health care workers to establish a diagnosis. Case Presentation: This case report discusses the presentation, clinical course, and outcome of a 14-day-old neonate, Baby C, who presented with a fever and rash and became a confirmed case after PCR testing. Conclusion: This case report underscores the need for heightened clinical vigilance in recognizing mpox in neonates, where the rarity of the disease, absence of clear exposure history, and overlap with common neonatal skin conditions may delay diagnosis. It will also add to the limited literature on neonatal mpox, which is a rare presentation to date.
Indexed as
Identifiers
42605412PMC13477723What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.